Skip to content

Prospective study for branch duct intraductal papillary mucinous neoplasms

Prospective study for branch duct intraductal papillary mucinous neoplasms - Prospective study forBD-IPMNs

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000004191
Enrollment
300
Registered
2010-10-01
Start date
2010-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraductal papillary mucinous neoplasm(IPMN)

Interventions

None listed

Sponsors

Kyoto University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1: diagnosed of BD-IPMN 2: diameter of MPD <10mm and height of mural nodule <5mm 3: any age and both sex is OK 4: Receive informed consent

Exclusion criteria

Exclusion criteria: 1: No informed consent 2: diameter of MPD ≥10mm and/or height of mural nodule ≥5mm 3: allergy for contrast 4: don't perform MRI 5: doctors judgement is not appropriate for this study

Design outcomes

Primary

MeasureTime frame
Rate of progression

Secondary

MeasureTime frame
Presence of new IPMN lesions, pancreatic cancers, extrapancreatic malignancies. How to progress BD-IPMNs

Countries

Japan

Contacts

Public ContactYuzo Kodama

Kyoto University Department of Gastroenterology and Hepatology

075-751-4319

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026